Dynamic Technology Lab’s Allogene Therapeutics ALLO Stock Holding History

Dynamic Technology Lab’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33K	Sell	15,866 -2,256	-12%	-$4.95K	0.01%	627
2026 Q1	$44.2K	Buy	+18,122	New	+$36.3K	0.01%	817
2025 Q4	–	Sell	-39,677	Closed	-$50K	–	718
2025 Q3	$50K	Buy	+39,677	New	+$47.3K	0.01%	754
2024 Q3	–	Sell	-14,085	Closed	-$33K	–	992
2024 Q2	$33K	Buy	+14,085	New	+$41.6K	﹤0.01%	892
2023 Q3	–	Sell	-33,095	Closed	-$164K	–	933
2023 Q2	$164K	Buy	+33,095	New	+$179K	0.02%	855
2022 Q4	–	Sell	-46,452	Closed	-$501K	–	1061
2022 Q3	$501K	Buy	+46,452	New	+$631K	0.05%	626
2021 Q3	–	Sell	-7,920	Closed	-$207K	–	1036
2021 Q2	$207K	Buy	+7,920	New	+$226K	0.02%	930

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Dynamic Technology Lab's ALLO Position: Q2 2026 in Review

Dynamic Technology Lab reduced its Allogene Therapeutics (ALLO) stake by 12% in Q2 2026, selling an estimated $4.95K and leaving 15,866 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #627.

Dynamic Technology Lab first reported a position in ALLO in Q2 2021 and has held it in 7 quarters since. The position peaked at $501K in Q3 2022. 210 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

Dynamic Technology Lab held 15,866 shares of Allogene Therapeutics worth $33K as of Q2 2026.
Dynamic Technology Lab sold 2,256 Allogene Therapeutics shares in Q2 2026, an estimated $4.95K.
Allogene Therapeutics made up 0.01% of Dynamic Technology Lab's portfolio in Q2 2026, its #627 holding.
Dynamic Technology Lab first reported a position in Allogene Therapeutics in Q2 2021 and has held it in 7 quarters since.
Dynamic Technology Lab's Allogene Therapeutics position peaked at $501K in Q3 2022.
210 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.